Interventions for preventing and managing advanced liver disease in cystic fibrosis-Reference-Cited by-同舟云学术

Interventions for preventing and managing advanced liver disease in cystic fibrosis

Published:2017-08-29 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Palaniappan Senthil K¹,Than Nan Nitra²,Thein Aung Win³,Moe Soe²,van Mourik Indra⁴

Affiliation:

1. NHS trust; Department of Medicine, University Hospitals of Leicester; Leicester Royal Infirmary Leicester UK LE1 5WW

2. Faculty of Medicine; Department of Community Medicine; Melaka-Manipal Medical College (MMMC) Jalan Batu Hampar Melaka Malaysia 75150

3. Melaka-Manipal Medical College; Department of Surgery; Jalan Batu Hampar, Bukit Baru Melaka Melaka Malaysia 75150

4. Birmingham Children's Hospital; Liver Unit; Steelhouse Lane Birmingham UK B4 6NH

Publisher

Wiley

Subject

Pharmacology (medical)

Reference102 articles.

1. Taurine improves the absorption of a fat meal in patients with cystic fibrosis;Belli;Pediatrics,1987

2. The effect of treatment with ursodeoxycholic acid in cystic fibrosis and hepatopathy: results of a placebo-controlled study;Bittner;Bile Acids As Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58.,1991

3. Bittner P Seiler T Ott H Posselt H-G Margdorf K Kawinkel M Therapeutical approach of ursodeoxycholic acid in cystic fibrosis and hepatopathy 16th Annual Meeting of the European Working Group for Cystic Fibrosis; 1989; Prague, Czechoslovakia 1989 72

4. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study;Colombo;Hepatology (Baltimore, Md.),1992

5. Colombo C Setchell KDR Podda M Crossignani A Assaisso ML Giunta A Ursodeoxycholic Acid (UDCA) in CF associated liver disease (LD): A dose response study 17th European Cystic Fibrosis Conference; 1991 Jun 18-21; Copenhagen, Denmark 1991 140

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results;Diagnostic and Interventional Radiology;2024-01-01

2. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis;Alimentary Pharmacology & Therapeutics;2022-01-19

3. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study;Journal of Cystic Fibrosis;2021-12

4. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators;Paediatric Respiratory Reviews;2020-12

5. Interventions for preventing and managing advanced liver disease in cystic fibrosis;Cochrane Database of Systematic Reviews;2020-03-30